Metastatic Sertoli cell carcinoma of the testis

M P. Mene, Larry Finkelstein, S. J. Manfrey, Larry Belkoff

Research output: Contribution to journalArticlepeer-review

Abstract

Metastatic Sertoli cell tumor is a very rare and deadly disease accounting for approximately 1% of all testicular carcinomas. With fewer than 30 cases reported in the literature, there has not been a uniform treatment regimen with good results. Retroperitoneal lymph node dissection, chemotherapy, and radiation therapy in combination appear to offer the best outcome. This report describes the occurrence of this rare tumor in a 38-year-old man 2 years after left orchiectomy.

Original languageAmerican English
JournalJournal of the American Osteopathic Association
Volume96
StatePublished - Jan 1 1996

Keywords

  • Adjuvant
  • Adjuvant chemotherapy
  • Chemotherapy
  • Combined Modality Therapy
  • Humans
  • Metastases
  • Neoplasm Metastasis
  • Sertoli cell tumor
  • Testicular Neoplasms
  • Tomography
  • Treatment outcome
  • X-Ray Computed
  • adult
  • case report
  • computer assisted tomography
  • human
  • male
  • metastasis
  • multimodality cancer therapy
  • orchiectomy
  • review
  • testis tumor

Disciplines

  • Oncology

Cite this